Federated Hermes, Inc. Cytom X Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 117 shares of CTMX stock, worth $124. This represents 0.0% of its overall portfolio holdings.

Number of Shares

117

Previous 117 -0.0%

Holding current value

$124

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$1.21 - $5.13 $5,167 - $21,910	-4,271 Reduced 97.33%	117 $0
Q1 2024 May 14, 2024	BUY	$1.41 - $2.74 $1,273 - $2,474	903 Added 25.91%	4,388 $9,000
Q4 2023 Jan 31, 2024	BUY	$1.07 - $1.55 $2,214 - $3,208	2,070 Added 146.29%	3,485 $5,000
Q1 2023 May 08, 2023	SELL	$1.48 - $2.88 $3,147 - $6,125	-2,127 Reduced 60.05%	1,415 $2,000
Q4 2022 Feb 13, 2023	SELL	$1.19 - $1.91 $850 - $1,365	-715 Reduced 16.8%	3,542 $5,000
Q3 2022 Nov 14, 2022	BUY	$1.23 - $1.97 $521 - $835	424 Added 11.06%	4,257 $6,000
Q2 2022 Aug 15, 2022	BUY	$1.53 - $2.89 $5,740 - $10,843	3,752 Added 4632.1%	3,833 $7,000
Q1 2022 May 13, 2022	SELL	$2.67 - $4.68 $2.57 Million - $4.5 Million	-961,393 Reduced 99.99%	81 $1,000
Q4 2021 Feb 14, 2022	SELL	$3.87 - $7.39 $476 - $908	-123 Reduced 0.01%	961,474 $4.16 Million
Q3 2021 Nov 15, 2021	BUY	$4.32 - $6.43 $127,828 - $190,263	29,590 Added 3.17%	961,597 $4.9 Million
Q2 2021 Aug 16, 2021	BUY	$6.33 - $9.91 $2.14 Million - $3.36 Million	338,586 Added 57.06%	932,007 $5.9 Million
Q1 2021 May 13, 2021	BUY	$6.6 - $9.0 $1.52 Million - $2.08 Million	230,763 Added 63.63%	593,421 $4.59 Million
Q4 2020 Feb 12, 2021	BUY	$6.47 - $7.9 $2.23 Million - $2.72 Million	344,186 Added 1863.28%	362,658 $2.38 Million
Q3 2020 Nov 12, 2020	BUY	$6.55 - $8.83 $76,327 - $102,895	11,653 Added 170.89%	18,472 $123,000
Q2 2020 Aug 13, 2020	BUY	$7.4 - $14.64 $50,460 - $99,830	6,819 New	6,819 $57,000
Q4 2019 Feb 14, 2020	SELL	$5.17 - $8.91 $36,034 - $62,102	-6,970 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.38 - $12.25 $51,438 - $85,382	6,970 New	6,970 $51,000
Q2 2018 Aug 10, 2018	SELL	$21.38 - $29.68 $2.69 Million - $3.74 Million	-125,932 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$21.76 - $34.22 $1.23 Million - $1.94 Million	56,582 Added 81.59%	125,932 $3.58 Million
Q4 2017 Feb 14, 2018	BUY	$19.0 - $23.09 $1.32 Million - $1.6 Million	69,350	69,350 $0

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.7M

Call Options Held

112K

Put Options Held

8.3K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Cytom X Therapeutics, Inc. Transaction History